Does This Pipeline Promise Tomorrow’s Blockbuster Sales?
DailyFinance
The company currently has six drugs and indications under review for regulatory approval, with 15 more therapies undergoing phase 3 trials as of May 6. Those 21 drugs in total match up well with some of the top pipelines in the business. As a …http://www.dailyfinance.com/2013/06/12/does-this-pipeline-promise-tomorrows-blockbuster-s/
